Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

GE HealthCare logoGE HealthCare GEHC

The company reaffirmed its 2024 outlook, with organic revenue growth of 1% to 2% trending toward the lower end of the range, adjusted EBIT margin of 15.8% to 16.0%, adjusted EPS of $4.25 to $4.35, and free cash flow of approximately $1.8 billion.

8-KRegulation FD DisclosureFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company reaffirmed its 2024 outlook, with organic revenue growth of 1% to 2% trending toward the lower end of the range, adjusted EBIT margin of 15.8% to 16.0%, adjusted EPS of $4.25 to $4.35, and free cash flow of approximately $1.8 billion.

  2. At its Investor Day, the company presented medium-term targets for 2026-2028 of organic revenue growth of 4% to 6%, adjusted EBIT margin of high-teens to 20%+, and free cash flow conversion of 90%+.

  3. The company said its Board of Directors declared a quarterly cash dividend of $0.035 per share of common stock for Q4 2024, an increase of 17% from the previous quarter. It said the dividend will be paid on February 14, 2025 to shareholders of record as of January 14, 2025.

  4. The company said it will hold its Investor Day on November 21, 2024 at the Nasdaq MarketSite in New York. Its discussion topics include financial and operational progress since the spin-off, growth opportunities by business segment, its innovation pipeline, and its AI and digital strategy.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Company Reaffirms 2024 Outlook

The company reaffirmed its 2024 outlook, with organic revenue growth of 1% to 2% trending toward the lower end of the range, adjusted EBIT margin of 15.8% to 16.0%, adjusted EPS of $4.25 to $4.35, and free cash flow of approximately $1.8 billion.

Source · Based on the filing body and exhibits

Sets 2026-2028 Medium-Term Financial Targets

At its Investor Day, the company presented medium-term targets for 2026-2028 of organic revenue growth of 4% to 6%, adjusted EBIT margin of high-teens to 20%+, and free cash flow conversion of 90%+.

Source · Based on the filing body and exhibits

Raises Quarterly Cash Dividend for Q4 2024

The company said its Board of Directors declared a quarterly cash dividend of $0.035 per share of common stock for Q4 2024, an increase of 17% from the previous quarter. It said the dividend will be paid on February 14, 2025 to shareholders of record as of January 14, 2025.

Source · Based on the filing body and exhibits

Investor Day Event and Discussion Topics

The company said it will hold its Investor Day on November 21, 2024 at the Nasdaq MarketSite in New York. Its discussion topics include financial and operational progress since the spin-off, growth opportunities by business segment, its innovation pipeline, and its AI and digital strategy.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.